Last week I spoke to the NIH biotechnology business leadership in Bethesda, Maryland. To the standing room only crowd, I laid out the challenges that we face over the next decade – the rising cost of new drug development, the increasingly poor odds … Continue reading at ComplianceZen.com →
From the Blog
FDA Training Records – 3 Risky Challenges
Should FDA Regulate Medical Apps?
3D Printing and Nanobots – FDA Challenges
From the Pharma Contracting & Outsourcing Conference
Medical Apps and FDA Regulation
Client Success Stories
“John truly shares his expertise and knowledge with you. During an audit we conducted together last year, he regularly gave the client practical and unbiased recommendations, making sure the focus was always on their ability to succeed, not just comply.”
- Jackie Cassada, President, Nottingham, England
